The Vα14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex

Journal of Immunology

Volumn 169, Issue 3, 2002, Pages 1340-1348

  Sidobre, Stéphane ^a   Naidenko, Olga V ^a   Sim, Bee Cheng ^a   Gascoigne, Nicholas R J ^a   Garcia, K Christopher ^a   Kronenberg, Mitchell ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSYLCERAMIDE; GLYCOLIPID; T LYMPHOCYTE RECEPTOR;

ALPHA HELIX; ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; BINDING AFFINITY; BONE MARROW CELL; CELL MEDIATED CYTOTOXICITY; COMPLEMENT ACTIVATION; COMPLEX FORMATION; IMMUNE RESPONSE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0036681960     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.3.1340     Document Type: Article

References (59)

1. The CDI system: Antigen-presenting molecules for T cell recognition of lipids and glycolipids
2. Presentation of self and microbial lipids by CDI molecules
3. + T lymphocytes
4. CDld-restricted mouse Vα14 and human Vα24 T cells: Lymphocytes of innate immunity
5. NKT cells: Facts, functions and fallacies
6. - NKT cells with distinct TCRαβ repertoires and differential distribution in lymphoid tissues
7. + NK T cells
8. Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor β repertoire and small clone size
9. CD1-mediated immune responses to glycolipids
10. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers
11. Tracking the response of natural killer T cells to a glycolipid antigen using CDld tetramers
12. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice
13. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells
14. Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis
15. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells
16. Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes
17. Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide
18. Rapid death and regeneration of NKT cells in anti-CD3ε- or IL-12-treated mice: A major role for bone marrow in NKT cell homeostasis
19. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10
20. +-like thymocytes in the NOD mouse
21. Extreme Th1 bias of invariant Va24JaQ T cells in type I diabetes
22. + effector function against intracellular infection
23. + TCRαβ intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro
24. CD1d-restricted immunoglobulin G formation to GP1-anchored antigens mediated by NKT cells
25. + T cells induces monocyte chemoattractant protein-1 in early listeriosis
26. + T lymphocytes
27. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors
28. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells
29. Ligand recognition by αβ T cell receptors
30. T cell receptor binding kinetics and special role of Vα in T cell development and activation
31. Les liaisons dangereuses
32. Mouse CD1 is mainly expressed on hemopoietic-derived cells
33. Tissue distribution, regulation and intracellular localization of murine CD1 molecules
34. Kinetics and thermodynamics of T cell receptor-autoantigen interactions in murine experimental autoimmune encephalomyelitis
35. Organization, structure, and function of 95 kb of DNA spanning the murine T-cell receptor Cα/Cδ region
36. The human T-cell receptor TCRAC/TCRDC (Cα/Cδ) region: Organization, sequence, and evolution of 97.6 kb of DNA
37. Phenotypic analysis of antigen-specific T lymphocytes
38. A kinetic basis for T cell receptor repertoire selection during an immune response
39. + NK T lymphocytes
40. Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells
41. Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CDld molecules
42. Structural requirements for antigen presentation by mouse CD1
43. Crystal structure of mouse CDI: An MHC-like fold with a large hydrophobic binding groove
44. Syntheses of biotinylated α-galactosylceramides and their effects on the immune system and CDI molecules
45. Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography
46. Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical
47. TCR binding to peptide-MHC stabilizes a flexible recognition interface
48. Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex
49. Crucial amino acid residues of mouse CD1d for glycolipid ligand presentation to Vα14 NKT cells
50. T cell receptor-MHC class I peptide interactions: Affinity, kinetics, and specificity
51. Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes
52. High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins
53. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes
54. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes
55. Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers
56. T cell receptor and coreceptor CD8α bind pepfide-MHC independently and with distinct kinetics
57. A population of murine γδ T cells that recognize an inducible MHC class Ib molecule
58. Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d
59. Structural requirements for glycolipid antigen recognition by CDIb-restricted T cells